Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC): final report, Volume 2
United States. Environmental Protection Agency. Endocrine Disruptor Screening and Testing Advisory Committee
Environmental Protection Agency, 1998 - Medical
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
agonists Analytical Cost Range Androgen Receptor antiandrogens Appendix assay ASSAY STABILITY assessment Availability body weight breast cancer cell line Chapter Four Appendices Citation Committee compounds cost estimates Data Source Description disruptors DOSES OR WEAKLY DURATION EDSTAC endocrine disruption endpoints Environmental estradiol estrogen receptor exposure FALSE NEGATIVES female rats Final Report Chapter fish flask histology Inclusion in EDPSD incubation Japanese quail KNOWN FALSE POSITIVES laboratories Leydig cells ligand LOW DOSES luciferase mammalian MVLN necropsy pesticides pipet precautionary principle procedures production progesterone protocol pups radioinert Recommended for Inclusion reporter gene reproductive response screening and testing SENSITIVITY TO LOW serum SPECIAL EQUIPMENT/REQUIREMENTS MANDATED SPECIAL SKILLS/TRAINING NEEDED specific STANDARDIZED EASILY steroid steroidogenesis substance testing program thyroid hormone Tier 1 Screening Tier 2 Tests tissue Toxicology transfected treatment tubes uterine weight Vitellogenin vitro vivo WEAKLY ACTIVE CHEMICALS xenobiotic xenoestrogens